Peter C. Taylor

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

Peter C. Taylor, Edward Keystone, Désirée van der Heijde et al. · New England Journal of Medicine · 2017 · 895 citations · Full text

Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

Ravinder N. Maini, Peter C. Taylor, Jacek Szechiński et al. · Arthritis & Rheumatism · 2006 · 789 citations

Moderate Folate Depletion Increases Plasma Homocysteine and Decreases Lymphocyte DNA Methylation in Postmenopausal Women

Robert A. Jacob, Denise Gretz, Peter C. Taylor et al. · Journal of Nutrition · 1998 · 483 citations

Epigenetic Change, Genetics, Clinical Nutrition +6

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritis

Peter C. Taylor, A. Michael Peters, Ewa Paleolog et al. · Arthritis & Rheumatism · 2000 · 401 citations

Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes

Myles Lewis, Michael R. Barnes, Kevin Blighe et al. · Cell Reports · 2019 · 380 citations · Full text